Case report: Use of bivalirudin to prevent thrombosis following orthotopic liver transplantation in a patient with Budd-Chiari syndrome and a history of heparin-induced thrombocytopenia

Annals of Clinical and Laboratory Science

Volumn 38, Issue 3, 2008, Pages 277-282

  Anderegg, Brent A ^a   Baillie, G Mark ^a   Uber, Walter E ^a   Chavin, Kenneth D ^b   Lin, Angello ^b   Baliga, Prabhakar K ^b   Lazarchick, John ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Bivalirudin; Budd Chiari syndrome; Heparin; Liver transplant; Thrombocytopenia; Thrombosis

Indexed keywords

ANTIVITAMIN K; BLOOD CLOTTING FACTOR 5; HEPARIN; HIRULOG; LEPIRUDIN; WARFARIN; ANTICOAGULANT AGENT; HIRUDIN DERIVATIVE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ADULT; ANTICOAGULATION; ARTICLE; BUDD CHIARI SYNDROME; CASE REPORT; CONTINUOUS INFUSION; DEEP VEIN THROMBOSIS; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEMATOTHORAX; HEPARIN INDUCED THROMBOCYTOPENIA; HISTORY; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; RISK REDUCTION; SIDE EFFECT; THROMBOCYTOPENIA; BLOOD CLOTTING; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; LIVER; METABOLISM; PARTIAL THROMBOPLASTIN TIME; THROMBOSIS;

ADULT; ANTICOAGULANTS; BLOOD COAGULATION; BUDD-CHIARI SYNDROME; DOSE-RESPONSE RELATIONSHIP, DRUG; FACTOR V; HEPARIN; HIRUDINS; HUMANS; LIVER; LIVER TRANSPLANTATION; MALE; PARTIAL THROMBOPLASTIN TIME; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; THROMBOCYTOPENIA; THROMBOSIS;

EID: 49749100739     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996;101:502-507.
2. Wallis DE, Workman DL, Lewis BE, et al. Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia: A prospective study. Am J Med 1999;106:629-635.
3. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126:311S-337S.
4. Narayanan-Menon KV, Shah V, Kamath PS. The Budd-Chiari Syndrome. NEJM 2004;350:578-585.
5. Denninger MH, Chait Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, Erlinger S, Briere J, Valla D. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000;31:587-591.
6. Sanchez-Bueno F, Robles R, Acosta F, Ramirez P, Lujan J, Munitiz V, Rios A, Parrilla P. Hepatic artery complications in a series of 300 orthotopic liver transplants. Transplant Proc 2000;32:2669-2670.
7. Turrion VS, Alvira LG, Jimenez M, Lucena JL, Ardaiz J. Incidence and results of arterial complications in liver transplantation: experience in a series of 400 transplants. Transplant Proc 2002;34:292-293.
8. Strange B, Settmacher U, Glanemann M, Nussler NC, Bechstein WO, Neuhaus P. Hepatic artery thrombosis after orthotopic liver transplantation. Transplant Proc 2001;33:1408-1409.
9. Zhao JC, Shi-Chun L, Lu-Nan LY, Li BO, et al. Incidence and treatment of hepatic artery complications after orthotopic liver transplantation. World J Gastroenterol 2003;9:2853-2855.
10. Pawlak J, Grodzicki M, Leowska E, Makowski P, Michalowicz B, Nyckowski P, et al. Vascular complications after liver transplantation. Transplant Proc 2003;35:2313-2315.
11. Parthi S, Rela M, Prachalias A, Paolo M, Portmann B, Jeelani Mufti G, et al. Liver transplantation for Budd-Chiari syndrome. Transplantation 2002;73:973-977.
12. Greinacher A. Recombinant hirudin for the treatment of heparin-induced thrombin-induced thrombocytopenia. In: Heparin-Induced Thrombocytopenia, 2nd ed (Warkentin TE, Greinacher A, Eds), New York, Marcel Dekker, 2001; pp 349-380.
13. Refludan. Prescriber information. Berlex, Montville, NJ, 2004.
14. Angiomax. Prescriber information. The Medicines Company, Parsippany, NJ, 2004.
15. Argatroban. Prescriber information. GlaxoSmithKline, Research Triangle Park, NC, 2005.